- Home
- IMCC vs SBFM Comparison
IMCC vs SBFM Comparison
Compare IMCC & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- SBFM
- Stock Information
- Founded
- IMCC 1980
- SBFM 2006
- Country
- IMCC Israel
- SBFM United States
- Employees
- IMCC N/A
- SBFM N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- IMCC Health Care
- SBFM Health Care
- Exchange
- IMCC Nasdaq
- SBFM Nasdaq
- Market Cap
- IMCC 12.0M
- SBFM 6.6M
- IPO Year
- IMCC N/A
- SBFM N/A
- Fundamental
- Price
- IMCC $2.95
- SBFM $1.54
- Analyst Decision
- IMCC
- SBFM Strong Buy
- Analyst Count
- IMCC 0
- SBFM 1
- Target Price
- IMCC N/A
- SBFM $15.00
- AVG Volume (30 Days)
- IMCC 148.9K
- SBFM 188.9K
- Earning Date
- IMCC 08-13-2025
- SBFM 08-15-2025
- Dividend Yield
- IMCC N/A
- SBFM N/A
- EPS Growth
- IMCC N/A
- SBFM N/A
- EPS
- IMCC N/A
- SBFM N/A
- Revenue
- IMCC $37,894,737.00
- SBFM $36,234,578.00
- Revenue This Year
- IMCC $47.12
- SBFM $192.48
- Revenue Next Year
- IMCC $12.83
- SBFM N/A
- P/E Ratio
- IMCC N/A
- SBFM N/A
- Revenue Growth
- IMCC 12.68
- SBFM 35.51
- 52 Week Low
- IMCC $1.29
- SBFM $1.17
- 52 Week High
- IMCC $7.12
- SBFM $7.18
- Technical
- Relative Strength Index (RSI)
- IMCC 51.60
- SBFM 51.91
- Support Level
- IMCC $2.37
- SBFM $1.43
- Resistance Level
- IMCC $3.75
- SBFM $1.61
- Average True Range (ATR)
- IMCC 0.38
- SBFM 0.11
- MACD
- IMCC 0.03
- SBFM 0.01
- Stochastic Oscillator
- IMCC 41.99
- SBFM 41.67
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.